Christopher Thibodeau has been named chief operating officer of OncoCell MDx. He joins Mark McDonough, recently appointed as OncoCell’s president, chief executive officer, and member of the board of directors, in strengthening the company’s executive leadership team.
How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.
